These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21545336)

  • 1. Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction.
    Guo BH; Cheng Y; Lin LP; Lin DH; Wu W
    J Liposome Res; 2011 Sep; 21(3):255-60. PubMed ID: 21545336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid.
    Mao SJ; Bi YQ; Jin H; Wei DP; He R; Hou SX
    Pharmazie; 2007 Aug; 62(8):614-9. PubMed ID: 17867558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid.
    Guo BH; Cheng Y; Wu W; Lin LP; Lin DH
    J Liposome Res; 2012 Jun; 22(2):120-7. PubMed ID: 22313057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of liposomes surface-modified with glycyrrhetinic acid targeting to hepatocytes].
    Mao SJ; Hou SX; Jin H; Zhang LK; Jiang-Bin
    Zhongguo Zhong Yao Za Zhi; 2003 Apr; 28(4):328-31. PubMed ID: 15139140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies of galactose-modified liver-targeting liposomes.
    Guo B; Cheng Y; Li N; Li X; Jin M; Li T; Li J
    J Drug Target; 2013 Apr; 21(3):257-264. PubMed ID: 23163746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
    Li J; Xu H; Ke X; Tian J
    J Drug Target; 2012 Jun; 20(5):467-73. PubMed ID: 22577855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome preparation using a hollow fiber membrane contactor--application to spironolactone encapsulation.
    Laouini A; Jaafar-Maalej C; Sfar S; Charcosset C; Fessi H
    Int J Pharm; 2011 Aug; 415(1-2):53-61. PubMed ID: 21641982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes.
    Peer D; Margalit R
    Arch Biochem Biophys; 2000 Nov; 383(2):185-90. PubMed ID: 11185552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positively and negatively charged liposomes as carriers for transdermal delivery of sumatriptan: in vitro characterization.
    Villasmil-Sánchez S; Drhimeur W; Ospino SC; Rabasco Alvarez AM; González-Rodríguez ML
    Drug Dev Ind Pharm; 2010 Jun; 36(6):666-75. PubMed ID: 20136486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
    Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
    Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome surface charge influence on skin penetration behaviour.
    Gillet A; Compère P; Lecomte F; Hubert P; Ducat E; Evrard B; Piel G
    Int J Pharm; 2011 Jun; 411(1-2):223-31. PubMed ID: 21458550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.
    Jaafar-Maalej C; Diab R; Andrieu V; Elaissari A; Fessi H
    J Liposome Res; 2010 Sep; 20(3):228-43. PubMed ID: 19899957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
    Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
    Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation.
    Chen J; Jiang H; Wu Y; Li Y; Gao Y
    Drug Des Devel Ther; 2015; 9():2265-75. PubMed ID: 25945038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of fluorinated catansomes: a promising vector in drug-delivery.
    Rosholm KR; Arouri A; Hansen PL; González-Pérez A; Mouritsen OG
    Langmuir; 2012 Feb; 28(5):2773-81. PubMed ID: 22149538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and in vivo study of liposomes mediated by glycyrrhetinic acid derivative ligand 18-GA-Gly].
    Jin S; Wang XL; Li G
    Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(21):4120-4126. PubMed ID: 29271149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the preparation of plasmid DNA-containing liposomes and their properties].
    Zhang HW; Sun X; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):298-300. PubMed ID: 16608100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
    Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
    Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.